Literature DB >> 22424197

Sjögren's syndrome, the old and the new.

Yogev Peri1, Nancy Agmon-Levin, Emanuel Theodor, Yehuda Shoenfeld.   

Abstract

Sjögren's syndrome is a chronic autoimmune disease characterised by progressive injury to exocrine glands accompanied by diverse extra-glandular manifestations. The spectrum of Sjögren's manifestations expanded in recent years to include new symptoms and signs such as small fibre neuropathy, and also well-defined activity and prognostic indexes. Similar to other non-organ-specific autoimmune diseases, a mosaic of factors have been linked with the development and appearances of Sjögren's syndrome. Progress has been made unravelling those factors, including susceptibility genes, immunological parameters and various environmental factors in the last decade, some of which may enable targeted therapies, biological and non-biological ones, for patients suffering from this disease. Thus, herein we review the postulated aetiologies, pathogenesis and new insights related to Sjögren's syndrome.
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22424197     DOI: 10.1016/j.berh.2012.01.012

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  51 in total

1.  Prevalence, severity, and predictors of dry eye and dry mouth in Chinese patients with primary Sjögren syndrome.

Authors:  Zhenyu Li; Ting Fu; Lin Li; Yafei Cui; Chen Dong; Jing Li; Zhifeng Gu
Journal:  Clin Rheumatol       Date:  2018-08-09       Impact factor: 2.980

2.  Sjogren's Syndrome and Pulmonary Disease.

Authors:  Ruben A Peredo; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Primary hyperparathyroidism and Gougerot disease.

Authors:  Toumader Bouziane; Nadia Belmahi; Hanan El Ouahabi
Journal:  Eur J Rheumatol       Date:  2017-11-02

Review 4.  Mouse Models of Primary Sjogren's Syndrome.

Authors:  Young-Seok Park; Adrienne E Gauna; Seunghee Cha
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren's syndrome.

Authors:  Sabrina Lisi; Margherita Sisto; Domenico Ribatti; Massimo D'Amore; Raffella De Lucro; Maria Antonia Frassanito; Loredana Lorusso; Angelo Vacca; Dario Domenico Lofrumento
Journal:  J Mol Med (Berl)       Date:  2014-02-21       Impact factor: 4.599

Review 6.  Progranulin: A key player in autoimmune diseases.

Authors:  Jinlong Jian; Guangfei Li; Aubryanna Hettinghouse; Chuanju Liu
Journal:  Cytokine       Date:  2016-08-12       Impact factor: 3.861

7.  A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

Authors:  Sarah Benchabane; Abdelhalim Boudjelida; Ryma Toumi; Houda Belguendouz; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  Int J Immunopathol Pharmacol       Date:  2016-05-19       Impact factor: 3.219

8.  Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.

Authors:  Sergio A Jimenez; Sonsoles Piera-Velazquez
Journal:  Autoimmun Rev       Date:  2013-05-15       Impact factor: 9.754

9.  Interleukin-6 deficiency corrects nephritis, lymphocyte abnormalities, and secondary Sjögren's syndrome features in lupus-prone Sle1.Yaa mice.

Authors:  Jacen S Maier-Moore; Christopher G Horton; Shirley A Mathews; Anthony W Confer; Christina Lawrence; Zijian Pan; K Mark Coggeshall; A Darise Farris
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

10.  Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.

Authors:  Sarah F Hamm-Alvarez; Srikanth R Janga; Maria C Edman; Sara Madrigal; Mihir Shah; Starleen E Frousiakis; Kavita Renduchintala; Jay Zhu; Seth Bricel; Kimberly Silka; Dianne Bach; Martin Heur; Stratos Christianakis; Daniel G Arkfeld; John Irvine; Wendy J Mack; William Stohl
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.